Navigation Links
FDA Commissioner Margaret Hamburg, Bestselling Author Jim Collins to Keynote RAPS Annual Conference in Philadelphia
Date:8/28/2009

Conference to Examine Latest in Healthcare Product Regulation, Trends, Technology

ROCKVILLE, Md., Aug. 28 /PRNewswire-USNewswire/ -- Professionals concerned with developing and bringing safe and effective drugs, medical devices, biotechnology and other healthcare products to the worldwide market will convene in Philadelphia next month for the Regulatory Affairs Professionals Society's (RAPS) 2009 Annual Conference & Exhibition. Attendees will come from around the world for what is the largest annual event of its kind exclusively for regulatory professionals in the healthcare product sector.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070314/DCW091LOGO )

New US Food and Drug Administration (FDA) Commissioner Margaret Hamburg, MD, who has gained attention since taking office for her public statements about refocusing FDA on its public health mission, will address attendees as this year's closing keynote speaker. The 2009 RAPS Annual Conference & Exhibition, the theme of which is "Succeed in the New Regulatory Landscape," will take place at Philadelphia's Pennsylvania Convention Center, 13-16 September. Bestselling business author Jim Collins of Good to Great fame will open the conference's first official day of sessions with a keynote address on Monday, 14 September. For more information and a complete listing of conference sessions and events, visit www.raps.org/ac2009. Follow conference updates on Twitter at @RAPSAnnualConf.

"Regulatory professionals play a vital role in ensuring access to safe and effective medicines, medical devices and myriad other healthcare products by the patients and healthcare professionals who need them every day," said RAPS Executive Director Sherry Keramidas, PhD, CAE. "It may not be thoroughly understood by the typical consumer, but these dedicated professionals are involved at every stage of healthcare product development and marketing. This conference is the premier event for regulatory professionals to gather, learn, network and hear from high-profile speakers like Dr. Hamburg and Jim Collins."

In addition to the keynote speakers, the conference will feature more than 25 additional senior FDA officials presenting at various sessions and briefings, as well as representatives from Japan's Ministry of Health Labor and Welfare (MHLW) and Pharmaceuticals and Medical Devices Agency (PMDA), the Drugs Controller General of India (DCGI) and the Dutch Healthcare Inspectorate as well as many other healthcare and regulatory experts from around the world.

Among the topics to be examined at the conference are regulation of biosimilars; considerations for clinical trials of stem cell products; regulations governing counter-bioterrorism agents; health technology assessment and its relationship to comparative effectiveness research; global clinical trials; international regulatory considerations for drugs, devices, biotechnology and combination products; regulatory challenges in emerging markets; advertising and promotion; postmarket surveillance and more. Attendees also will receive briefings from representatives of FDA's Center for Devices and Radiological Health (CDRH) and Center for Drug Evaluation and Research (CDER), the European Medicines Agency (EMEA) and Health Canada.

Members of the working media wishing to cover all or part of the 2009 RAPS Annual Conference & Exhibition should contact RAPS Communications Manager Zachary Brousseau at zbrousseau@raps.org or +1 301 770 2920, ext. 245. On-site registration also will be available and members of the media must bring valid press credentials or a letter from an assigning editor on company letterhead.

Conference sponsors include: Anson Group, BSI Healthcare, Crimson/Transperfect, Elsevier Business Intelligence, GE Healthcare, Kendle, Prolifiq Software, Stericycle and Tarius.

About RAPS

The Regulatory Affairs Professionals Society (RAPS) is an international membership organization of regulatory professionals in the rapidly growing medical device, pharmaceutical and biotechnology sectors. Regulatory professionals play vital roles in making better healthcare products possible. They work throughout the healthcare product lifecycle, ensuring these products are safe and effective, while driving organizational strategy and sound decision-making. RAPS supports these individuals and the regulatory profession by providing education and training, Regulatory Affairs Certification (RAC), professional standards, research, knowledge-sharing, publications, networking, career development opportunities and other valuable resources; and is committed to helping its members continually develop the knowledge and skills they need to excel. RAPS is headquartered near Washington, DC, with offices in Brussels and Tokyo. RAPS.org


'/>"/>
SOURCE Regulatory Affairs Professionals Society (RAPS)
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. AIDS Healthcare Foundation Applauds City Commissioners Support of Diversity, Urges Call for Mayors Resignation
2. Governor Rendell Directs Insurance Commissioner to Delay Mcare Abatement Collection
3. Providing Affordable Health Care Coverage Cited as a Top Priority, Commissioner Says
4. Council on Education in Management Announces Insurance Commissioner Steve Poizner Will Present Keynote Address at the 6th Annual California Workers' Comp Forum
5. Council on Education in Management Announces New Commissioner Rod Bordelon will Present a Keynote Address at the 5th Annual Texas Workers' Comp Forum
6. Insurance Commissioner Announces Retirement of George Hoover
7. Kansas Insurance Commissioner, Sandy Praeger, to Appear this Saturday on Cary Hall's Health Insurance Advocate Radio Show
8. Pennsylvania Insurance Commissioner Welcomes U.S. House Vote to Reauthorize Childrens Health Care
9. Light Sciences Oncology Elects Former FDA Commissioner Frank Young, M.D., Ph.D., to Board of Directors
10. Pennsylvania Insurance Commissioner Praises Federal Reauthorization of Childrens Health Care
11. AstraZeneca Applauds Appointment of New FDA Commissioner
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... ... , ... SC&H Group, a leading audit, tax, and consulting firm, announced that ... Services practice . Rossi is the third technology consulting leader to join SC&H Group’s ... and the practice continues to expand.     , Bringing more than 25 years of business ...
(Date:1/17/2017)... ... January 17, 2017 , ... Physicians ... Sandra Lee as keynote speaker for the 34th Annual Miami Breast Cancer Conference®, ... the announcement, PER® president, Phil Talamo, said, “We are delighted to have Sandra ...
(Date:1/17/2017)... ... ... people make New Year’s resolutions or renew their commitment to better health with the start ... who want to kick off 2017 with better smiles. Dr. Mondavi is offering several promotions ... include: , , A new patient package for just $49, which ...
(Date:1/16/2017)... ... January 17, 2017 , ... To provide comfort and fuel ... the fast-casual category, announces a hearty and wholesome Winter Menu. Starting today, guests ... Mash-Up Sandwich, Cranberry Crunch & Honey Parfait, Slow Cooked Smoky Chicken & Sausage ...
(Date:1/16/2017)... , ... January 16, 2017 , ... Gym Source, America’s ... a new showroom in East Hanover, New Jersey. , “We are elated to be ... new innovative in-store concept is designed to give clients a seamless and motivating shopping ...
Breaking Medicine News(10 mins):
(Date:1/17/2017)... , Jan 17, 2017 Research and Markets ... System Market 2016-2020" report to their offering. ... The global artificial pancreas devices ... period 2016-2020. Global Artificial Pancreas Devices System Market 2016-2020, ... from industry experts. The report covers the market landscape and its ...
(Date:1/17/2017)... Jan. 17, 2017 Paragon Bioservices received a ... development services for a variety of National ... medical product development activities. The IDIQ mechanism will ... for task order awards up to $159 million. ... manufacturing and process development of biopharmaceuticals, is one ...
(Date:1/17/2017)... , Jan. 17, 2017  Jazz Pharmaceuticals plc (Nasdaq: ... has been enrolled in a Phase 3 clinical trial ... supportive care (BSC) in the prevention of hepatic veno-occlusive ... stem cell transplant (HSCT) who are at high risk ... defibrotide clinical trial will be conducted across approximately 100 ...
Breaking Medicine Technology: